Identification of high-risk types: Such as HPV 16 and 18, which are linked to an increased risk of cervical cancer and other tumors. Detection of low-risk types: Which may cause skin or genital warts but are not directly linked to cervical cancer. Health risk assessment: Knowing the types present helps determine potential risks for malignant tumors and guides appropriate healthcare. Monitoring vaccine effectiveness: Understanding which HPV types a person is exposed to can help assess the effectiveness of HPV vaccines.

Women who have undergone cervical screenings: Especially if the results show abnormal changes. Individuals with HPV-related symptoms: Such as genital or skin warts. Women in the appropriate age group: Typically between 30 and 65 years, for regular HPV screening. Individuals identified as HPV carriers: To determine the virus type and assess associated health risks. Individuals wishing to assess post-exposure risks: To help make informed decisions regarding monitoring and treatment.

Abnormal cervical screening results: such as a positive Pap smear result. Appearance of genital warts: lumps or warts on or around the genital area. Unexplained bleeding: bleeding between menstrual periods or after sexual intercourse. Pelvic pain or discomfort: feeling pain or discomfort in the pelvic area that may require a thorough examination. Family history of cervical cancer: genetic factors can increase the likelihood of infection or complications.

What is Human Papillomavirus (HPV)? It is a group of viruses that can cause warts and cancerous diseases, including cervical cancer. Why is HPV Genotyping performed? To identify the different types of HPV in the sample, which helps assess health risks. How is the test performed? It requires collecting a sample from a cervical swab or other tissue samples. Which types can be identified through this test? Both high-risk types (e.g., HPV 16 and 18) and low-risk types can be detected. What are the possible results? The result can be negative (no virus present) or positive (virus detected), with identification of the type. What does the presence of a high-risk type mean? It indicates an increased risk of cervical cancer, requiring closer follow-up. Are there any risks associated with this test? The test is generally safe, though minor discomfort may occur when taking the sample.

Negative Result: Indicates no HPV virus is present in the sample, meaning the person is not a carrier. Positive Result: Indicates the presence of HPV virus and identifies its type: High-risk types: Such as HPV 16 and 18, associated with an increased risk of cervical cancer. Low-risk types: May cause skin or genital warts, but are not directly linked to cancer. High-risk types: Such as HPV 16 and 18, associated with an increased risk of cervical cancer. Low-risk types: May cause skin or genital warts, but are not directly linked to cancer.

HPV Genotyping Test Price | Lahalak Medical Platform

An advanced test using Real-Time PCR to accurately identify HPV types, helping assess infection risk and enable early detection for informed preventive decisions.

Prices starts from: 443.52 SAR

Scientific name: HPV Genotyping (Real-Time PCR)

HPV Genotyping analysis using Real-Time PCR is a precise procedure used to identify the types of HPV present in biological samples, such as cervical swabs. HPV is one of the primary causes of cervical cancer, and identifying the type of virus can help assess individual health risks. This technique allows for the identification of high-risk types, s...

HPV Genotyping (Real-Time PCR) - Precise HPV Genotyping

Service type Medical Swab (PCR)

Duration 15-20 minutes

Fasting Fasting is not required

Prices Starting from 443.52 SAR

Included Services

HPV Genotyping (Real-Time PCR) Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

Identification of high-risk types: Such as HPV 16 and 18, which are linked to an increased risk of cervical cancer and other tumors.
Detection of low-risk types: Which may cause skin or genital warts but are not directly linked to cervical cancer.
Health risk assessment: Knowing the types present helps determine potential risks for malignant tumors and guides appropriate healthcare.
Monitoring vaccine effectiveness: Understanding which HPV types a person is exposed to can help assess the effectiveness of HPV vaccines.

Recommended groups

Women who have undergone cervical screenings: Especially if the results show abnormal changes.
Individuals with HPV-related symptoms: Such as genital or skin warts.
Women in the appropriate age group: Typically between 30 and 65 years, for regular HPV screening.
Individuals identified as HPV carriers: To determine the virus type and assess associated health risks.
Individuals wishing to assess post-exposure risks: To help make informed decisions regarding monitoring and treatment.

Symptoms indicative

Abnormal cervical screening results: such as a positive Pap smear result.
Appearance of genital warts: lumps or warts on or around the genital area.
Unexplained bleeding: bleeding between menstrual periods or after sexual intercourse.
Pelvic pain or discomfort: feeling pain or discomfort in the pelvic area that may require a thorough examination.
Family history of cervical cancer: genetic factors can increase the likelihood of infection or complications.

FAQs

What is Human Papillomavirus (HPV)? It is a group of viruses that can cause warts and cancerous diseases, including cervical cancer.
Why is HPV Genotyping performed? To identify the different types of HPV in the sample, which helps assess health risks.
How is the test performed? It requires collecting a sample from a cervical swab or other tissue samples.
Which types can be identified through this test? Both high-risk types (e.g., HPV 16 and 18) and low-risk types can be detected.
What are the possible results? The result can be negative (no virus present) or positive (virus detected), with identification of the type.
What does the presence of a high-risk type mean? It indicates an increased risk of cervical cancer, requiring closer follow-up.

Normal Levels

Negative Result: Indicates no HPV virus is present in the sample, meaning the person is not a carrier.
Positive Result: Indicates the presence of HPV virus and identifies its type: High-risk types: Such as HPV 16 and 18, associated with an increased risk of cervical cancer. Low-risk types: May cause skin or genital warts, but are not directly linked to cancer.
High-risk types: Such as HPV 16 and 18, associated with an increased risk of cervical cancer.
Low-risk types: May cause skin or genital warts, but are not directly linked to cancer.